More on RNLXY

- Summary
- Chart
- Profile
- Historical

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

(OP:RNLXY)
Delayed: 2.77 +0.27 (10.80%)
Prev. Close $2.50  
Open$2.66 
52 Wk High$ 
52 Wk Low$ 
Day High$2.77 
Day Low$2.50 
P/E N/A  
EPS$ 
Volume120,563 

Friends, Peers and Foes (?): 2O9 RENX (more...)

Jun 30, 2026 07:43 AM KidneyIntelX® Delivers Unprecedented Two-Year Real-World Outcomes in Diabetic Kidney Disease: No Comparable Risk Assessment Tool Exists
May 12, 2026 07:43 AM Renalytix™ and Carna Health Partner to Solve Kidney Disease Crisis: Bridging the Existing Gap Between Population Screening and Precision Intervention
Feb 23, 2026 04:21 PM Form SCHEDULE 13D/A Renalytix plc Filed by: JEFFERSON RIVER CAPITAL LLC
Dec 3, 2025 04:07 PM Form F-6 POS Renalytix plc Filed by: Citibank,N.A./ADR
Nov 18, 2025 07:51 AM Pivotal kidneyintelX.dkd Data Published in Diabetes Care, Considered the Leading Clinical Journal Worldwide in Diabetes
Sep 15, 2025 08:01 AM Renalytix partners with Tempus AI to expand kidney disease testing
Sep 15, 2025 08:00 AM Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease
Sep 4, 2025 02:05 PM Form F-6 POS Renalytix plc Filed by: Citibank,N.A./ADR
View All Articles

Entities mentioned with RNLXY

View All Entities